U.S. FDA Issues Official Action Indicated Notice to Aurobindo’s Formulation Unit, Signaling Regulatory Escalation
The U.S. Food and Drug Administration has classified a formulation manufacturing unit operated by Aurobindo Pharma Limited as subject to an Official Action Indicated (OAI)…